CLINICAL_TRIALS trial_result · 2020-09-01

Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age [Phase 4]

Phase 4 trial evaluating safety and immunogenicity of tOPV in 1-5 years and at 6 weeks of age for poliomyelitis; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Fidec Corporation | Conditions: Poliomyelitis | Phase 4 | Status: COMPLETED | Results posted: 2020-09-01